MEF2D and non-small cell lung carcinoma: Further data mining demonstrated significantly higher MEF2D level in COPD patients with NSCLC than that in smokers, patients with COPD and no NSCLC, or patients with NSCLC and no COPD, compared with healthy non-smokers (Fig. 1d, p < 0.001).